Table 4 Changes in antidiabetic medication during the study (After 3 months of follow-up) n = 585
Agent | Sulfonylurea | Biguanide | Thiazolidinedione | α-Glucosidase inhibitors | Sitagliptin |
|---|---|---|---|---|---|
Patients who received additional antidiabetic agent(s) | 26 | 18 | 9 | 2 | 0 |
Patients who increased dosage | 8 | 26 | 0 | 0 | 86 |
Patients who decreased dosage | 7 | 4 | 0 | 0 | 2 |
Patients who stopped receiving agent(s) | 8 | 3 | 20 | 0 | 0 |